If enacted, ACR 104 would impact state health policies significantly by advocating for the integration of hepatitis screenings and vaccinations into routine health care practices across California. The resolution underscores the necessity of having health institutions implement systematic protocols to identify and treat infections, thereby positioning such measures as essential to public health. With approximately 300,000 and 400,000 Californians infected with hepatitis B and C respectively, the resolution supports initiatives that aim for broader screening and treatment access.
Summary
Assembly Concurrent Resolution No. 104, introduced by Low, aims to recognize July 28 as World Hepatitis Day in California and urges various community stakeholders to commit to standard screenings and vaccinations for hepatitis B and C. Given the alarming rates of these viral infections, the resolution emphasizes the dire need for increased awareness and preventive health measures, highlighting that hepatitis B and C remain major causes of liver cancer and related illnesses not only in California, but globally.
Sentiment
The sentiment surrounding ACR 104 is largely positive, viewed as a vital step in advancing public health awareness and action against hepatitis infections. Supporters argue that the resolution provides an essential framework to combat the rising rates of liver disease through education and systematic health practices. By addressing the known gaps in awareness and care, the resolution is seen as a means to mobilize resources and foster community engagement in preventative health efforts.
Contention
Despite the general support for ACR 104, points of contention include the challenge of implementation in diverse communities, especially among vulnerable populations who may be less likely to engage with health systems. There are concerns regarding the disparity in health access and the effectiveness of outreach efforts in ensuring that marginalized groups receive appropriate screenings and vaccinations. Moreover, while the resolution urges specific actions, it does not provide direct funding mechanisms for the proposed initiatives, which could limit its effectiveness.
Requires hospital laboratories and bio-analytical or clinical laboratories to offer test for hepatitis C to certain individuals; authorizes certain laboratories to perform rapid tests for hepatitis C.
Requires hospital laboratories and bio-analytical or clinical laboratories to offer test for hepatitis C to certain individuals; authorizes certain laboratories to perform rapid tests for hepatitis C.